We are a pharmaceutical company with more than a century of history dedicated to transforming the lives of people living with chronic diseases, such as diabetes, obesity, and other serious chronic conditions, like hemophilia. Founded in 1923 in Denmark, Novo has evolved to become a global leader in the development of innovative therapies, with a strong commitment to biotechnological innovation, research, and prevention, as well as the development of digital health solutions